Description
Clinical Description
VITARAN Eyes is a CE-marked polynucleotide (PDRN) injectable from the VITARAN range, formulated with highly purified salmon-trout DNA fragments. Its active component is polynucleotide sodium, at a concentration of 20 mg/ml (PN 2%). Unlike hyaluronic acid fillers that volumize via gel, VITARAN Eyes acts as a bio-revitalising skin booster: PDRN fragments are intended to stimulate dermal regeneration, promote fibroblast activity, collagen and elastin synthesis, thereby supporting skin repair, improving skin elasticity and quality in thin, delicate peri-ocular skin. The formulation is specifically designed for under-eye / periorbital applications, addressing signs of skin ageing, fine lines, loss of elasticity or skin dullness rather than volumetric augmentation.
What VITARAN Eyes Is Similar To
VITARAN Eyes belongs to the class of polynucleotide (PDRN) skin boosters rather than traditional hyaluronic acid (HA) fillers. It serves a purpose similar to regenerative boosters that emphasize skin quality, hydration, and collagen stimulation — rather than structural volume restoration. For orientation, it can be compared to lighter skin-boosting injectables such as certain PDRN-based eye boosters or “skin-revitalizers” used for thin periocular skin, which also aim to improve elasticity, firmness, and skin texture. In contrast to HA fillers (designed to volumize, contour, or fill deep wrinkles), VITARAN Eyes focuses on tissue renewal and superficial skin enhancement. Because its mechanism and target outcome differ from volumizing fillers, it should not be regarded as an alternative when volume or deep contour correction is required. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
-
Under-eye / periorbital region, thin and delicate skin zones.
-
The product is specifically supplied for under-eye applications; other areas are not listed publicly for this formulation.
Usage / Administration (IFU-only section)
-
Injection depth / method: Not provided by manufacturer. Public listings describe VITARAN Eyes as a “skin-booster / polynucleotide injectable” for under-eye treatment.
-
Needle gauge / included needle: Supplied with a 33G needle.
-
Volume per point / injection site: Not provided by manufacturer.
-
Frequency / number of sessions: Not provided by manufacturer. Some providers of related polynucleotide injectables (e.g. other VITARAN formats) suggest treatment protocols every 2–4 weeks, but this refers to a different product version and not explicitly VITARAN Eyes.
-
Professional-use disclaimer: VITARAN Eyes is provided only to qualified aesthetic practitioners trained in polynucleotide or skin-booster protocols and should be used under aseptic conditions.
Because the publicly available documentation does not include a full IFU specifying injection depth, site volume, or session frequency, practitioners must refer to the official IFU supplied with the product for final treatment parameters.
Ingredient List
-
Polynucleotide sodium (PDRN) — 20 mg/mL (PN 2%)
-
Buffer / solvent (q.s.) — as per manufacturer composition listing
No hyaluronic acid, lidocaine, or cross-linked HA gel matrix is declared for this product in publicly available sources.
Presentation & Longevity
-
Packaging: 1 × 1 mL pre-filled syringe, supplied with 33G needle.
-
Shelf life / expiry: Not provided by manufacturer in publicly accessible documentation.
-
Expected duration of effect: Not provided by manufacturer — as a bio-revitalising skin booster rather than a volumizing filler, longevity depends on biological response, skin condition, and post-treatment care.
Safety Notes / Contraindications
According to publicly available contraindication listing for VITARAN Eyes:
-
Must not be used in individuals under 18 years of age.
-
Contraindicated in pregnant or breastfeeding women.
-
Contraindicated in individuals with fish (salmon-trout) allergy or hypersensitivity to any product component.
-
Contraindicated in presence of active skin infection or inflammation at the injection site.
-
Contraindicated in individuals prone to keloid formation, with autoimmune disease, or on immunosuppressants / blood-thinning medication.
Standard caution: Use is contraindicated in patients with known hypersensitivity to any component or active skin infection at the injection site. Injections must be performed by qualified professionals.
Regulatory Status
-
CE-marked medical-aesthetic polynucleotide injectable.
-
No publicly available information explicitly confirms UKCA marking — practitioners should verify regulatory labeling on the product packaging or official IFU before import or use in the UK.
FAQ
Q1: What does PDRN in VITARAN Eyes do?
A1: PDRN (polynucleotide sodium) consists of purified DNA fragments — in this case derived from salmon-trout — that act as bio-stimulators when injected into skin tissue. Through cellular signalling, PDRN may stimulate fibroblast activity, encourage collagen and elastin synthesis, enhance skin regeneration, and support extracellular matrix repair. This mechanism aims to improve skin elasticity, firmness, and overall skin quality rather than add volume.
Q2: Will VITARAN Eyes add volume under the eyes like a filler?
A2: No. VITARAN Eyes is not a volumising filler — it does not contain hyaluronic acid gel or cross-linked HA designed for tissue expansion. Its purpose is bio-revitalisation and skin quality improvement. Use of VITARAN Eyes should not be expected to produce the same volumetric or contour-defining effect as HA dermal fillers.
Q3: For which areas is VITARAN Eyes intended?
A3: Public distributor information specifies VITARAN Eyes for the under-eye / periorbital area (thin, delicate skin).Use in other facial or body areas is not indicated in the publicly available product description for this formulation.
Q4: Is there a standard injection protocol for VITARAN Eyes?
A4: The manufacturer’s publicly available documentation does not provide a full injection protocol (injection depth, volume per point, frequency). Only that the product comes with a 33G needle and is designated for under-eye skin-boosting injections by qualified clinicians. Clinics should follow official IFU guidelines (when received) and standard aseptic procedures.
Q5: What safety considerations apply when using VITARAN Eyes?
A5: Use is contraindicated in minors, pregnant or breastfeeding women, individuals with fish allergies or known hypersensitivity to any components, and patients with active skin infections or inflammatory skin conditions. Also contraindicated in those prone to keloid scarring, autoimmune conditions, or on immunosuppressive/blood-thinning therapy. Injections must be performed by trained professionals under sterile conditions.
